The China National Medical Products Administration (NMPA) has granted expanded approval to MSD's GARDASIL, [Human ...

Human Papillomavirus (HPV) is a widespread sexually transmitted infection, affecting nearly 80 percent of sexually active ...

The recipient in Changsha, the capital of Hunan province, became the first man on the Chinese mainland to receive the HPV ...

Creative Diagnostics, a leading manufacturer and supplier of antibodies, antigens and assay kits, announces the launch of its high-performance HPV IgG ELISA Kit for the sensitive and specific ...

HPV-16 E7 is under clinical development by Gilead Sciences and currently in Phase II for Oropharyngeal Cancer.

HPV-16 E7 is under clinical development by Gilead Sciences and currently in Phase II for Human Papillomavirus (HPV) Associated Cancer.

China NMPA grants expanded approval for Merck’s Gardasil for use in males 9-26 years of age to help prevent certain HPV-related cancers & diseases: Rahway, New Jersey Friday, Ja ...

Approximately 11,500 new cases of cervical cancer are diagnosed each year and, sadly, roughly 4,000 women will succumb to the disease, according to the Centers for Disease Control and Prevention. But ...

GARDASIL is the first HPV vaccine approved for the prevention of certain HPV-related cancers and diseases in Chinese males ...

The HPV vaccine, Gardasil, has gained approval for additional indications from China's National Medical Products ...